The global Assisted Reproductive Technology (ART) market was valued at approximately USD 44 billion in 2023 and is projected to reach USD 55.63 billion by 2030, growing at a CAGR of 3.4% during the forecast period. From 2017 to 2021, the market recorded a strong CAGR of 4.11%, demonstratin